Obesity Clinical Trial
— MAWIOfficial title:
Using Mental Imagination to Prevent Excessive Gestational Weight Gain in Overweight and Obese Pregnant Women
Verified date | June 2023 |
Source | Ohio State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Moms Are Worth It is a lifestyle behavior intervention study aims to prevent excessive gestational weight gain in overweight or obese pregnant women through promotion of the stress management, healthy eating, and physical activity. Eligible women will be randomly assigned to a usual care or an intervention plus usual care group. The intervention will last 20 weeks and will be delivered via weekly web and individual health coaching session (10 of them)
Status | Active, not recruiting |
Enrollment | 90 |
Est. completion date | December 30, 2023 |
Est. primary completion date | January 30, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - Participants must be pregnant women = 13 week-gestation with a single fetus as assessed by ultrasound. - Participants must also have self-reported pre-pregnancy body mass index (BMI) of 25.0-45.0 kg/m2 and height (height and weight to compute body mass index). - Ability to read and speak English, - Age of 18-45 years, - Access to a working smart phone with unlimited text messaging, - Access to internet, - Receipt of prenatal care from our collaborating clinics and plan to deliver the baby at The Ohio State University (OSU) Wexner Medical Center, - Resident of Franklin Count, - Committed to the 20-week intervention. Exclusion Criteria: - Self-reported history of = 3 miscarriages, - Planned termination of the pregnancy, - Diagnosed hypertension and/or type 1 or 2 diabetes, - History of or current diagnosis of an eating disorder, - Serious current physical disease (e.g., renal disease or cancer), - Past bariatric surgery, - Current or history of substance abuse in the past 6 months, - Current treatment for a serious psychological disorder (e.g., schizophrenia and bipolar disorder), - Contraindications to walking, - Consented women will become not eligible to participate in the study if they are not randomized by 16-week 6 days gestation. This is because the study intervention starts = 17 weeks gestation. - Women will become not ineligible for participation if they did not complete the baseline data. |
Country | Name | City | State |
---|---|---|---|
United States | The Ohio State University | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Ohio State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Body weight | Data extracted from electronic medical record | Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Primary | Change in Body weight | Data extracted from electronic medical record | 24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Primary | Change in Body weight | Data extracted from electronic medical record | Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Gestational Diabetes status | Data extracted from electronic medical record | 24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Gestational Hypertension status | Data extracted from electronic medical record | 24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Mode of Delivery | Data extracted from electronic medical record | 35-37 week-gestation (T3) | |
Secondary | Newborn body weight | Data extracted from electronic medical record. | 35-37 week-gestation (T3) | |
Secondary | Gestational age at birth | Data extracted from electronic medical record.
The higher value, the higher gestational age |
35-37 week-gestation (T3) | |
Secondary | Change in Dietary Intake Behaviors | Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants will complete 24-hour Recalls on two random days over a week. The variables of interest include calories, fat, sugary drinks, fruit and vegetable intakes. The higher scores indicate higher caloric, fat, sugary drinks, fruit and vegetable intakes. | Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Dietary Intake Behaviors | Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants will complete 24-hour Recalls on two random days over a week. The variables of interest include calories, fat, sugary drinks, fruit and vegetable intakes. The higher scores indicate higher caloric, fat, sugary drinks, fruit and vegetable intakes. | 24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Dietary Intake Behaviors | Assessed using the National Cancer Institute Automated Self-Administered 24-hour Recall (ASA24). Participants will complete 24-hour Recalls on two random days over a week. The variables of interest include calories, fat, sugary drinks, fruit and vegetable intakes. The higher scores indicate higher caloric, fat, sugary drinks, fruit and vegetable intakes. | Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Physical Activity | Assessed using Actigraph (GT3x), an objective measurement of physical activity. Investigators will distribute the Actigraph in person participants' home (T2 and T3) to wear at the wrist at least seven consecutive days (= 10 hours/per day). The higher score, the higher physical activity. | Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Physical Activity | Assessed using Actigraph (GT3x), an objective measurement of physical activity. Investigators will distribute the Actigraph in person participants' home (T2 and T3) to wear at the wrist at least seven consecutive days (= 10 hours/per day). The higher score, the higher physical activity. | 24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Physical Activity | Assessed using Actigraph (GT3x), an objective measurement of physical activity. Investigators will distribute the Actigraph in person participants' home (T2 and T3) to wear at the wrist at least seven consecutive days (= 10 hours/per day). The higher score, the higher physical activity. | Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Autonomous Motivation for Stress Management | Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for stress management (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for stress management. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Autonomous Motivation for Healthy Eating | Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Healthy Eating (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for Healthy Eating. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Autonomous Motivation for Physical Activity | Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Physical Activity (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for Physical Activity. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Autonomous Motivation for Stress Management | Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Stress Management (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for Stress Management. |
24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Autonomous Motivation for Healthy Eating | Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Healthy Eating (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for Healthy Eating. |
24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Autonomous Motivation for Physical Activity | Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Physical Activity (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for physical activity. |
24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Autonomous Motivation for Stress Management | Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for stress management (6 items)
Values are: 1 - Not At AllTrue, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for stress managment. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Autonomous Motivation for Healthy Eating | Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Healthy Eating (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for Healthy Eating |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Autonomous Motivation for Physical Activity | Will be measured using Treatment Self-Regulation Questionnaire (6 items) to measure autonomous motivation for Physical Activity (6 items)
Values are: 1 - Not At All True, 2, 3, 4 - Somewhat True, 5, 6, 7 - Very True The investigators will sum 6 items to create a composite score, ranging from 6 to 42. Higher scores indicate higher autonomous motivation for Physical Activity. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Coping Self-efficacy | Will be measured using a "Survey for Coping Self-efficacy" (10 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum 10 items to create a composite score, ranging from 10 to 40. Higher scores indicate higher coping self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Coping Self-efficacy | Will be measured using a "Survey for Coping Self-efficacy" (10 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum 10 items to create a composite score, ranging from 10 to 40. Higher scores indicate higher coping self-efficacy. |
24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Coping Self-efficacy | Will be measured using a "Survey for Coping Self-efficacy" (10 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum 10 items to create a composite score, ranging from 10 to 40. Higher scores indicate higher coping self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Healthy Eating Self-efficacy | Will be measured using a "Survey for Healthy Eating Self-efficacy" (8 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident. The investigators will sum all 8 items to create a composite score, ranging from 8 to 32. The higher score, the higher healthy eating self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Healthy Eating Self-efficacy | Will be measured using a "Survey for Healthy Eating Self-efficacy" (8 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum all 8 items to create a composite score, ranging from 8 to 32. The higher score, the higher healthy eating self-efficacy. |
24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Healthy Eating Self-efficacy | Will be measured using a "Survey for Healthy Eating Self-efficacy" (8 items)
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum all 8 items to create a composite score, ranging from 8 to 32. The higher score, the higher healthy eating self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Physical Activity Self-efficacy | Will be measured using a "Survey for Physical Activity Self-efficacy" (10 items) that ask participants' confidence in performing the specific activity.
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum all 10 items to create a composite score, ranging from 10 to 40. The higher score, the higher physical activity self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Physical Activity Self-efficacy | Will be measured using a "Survey for Physical Activity Self-efficacy" (10 items) that ask participants' confidence in performing the specific activity.
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum all 10 items to create a composite score, ranging from 10 to 40. The higher score, the higher physical activity self-efficacy. |
24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Physical Activity Self-efficacy | Will be measured using a "Survey for Physical Activity Self-efficacy" (10 items) that ask participants' confidence in performing the specific activity.
Values are: 1 - Not At All Confident, 2 - Not Too Confident, 3 - Somewhat Confident, 4 - Very Confident The investigators will sum all 10 items to create a composite score, ranging from 10 to 40. The higher score, the higher physical activity self-efficacy. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Emotion Regulation | Will be measured using the Emotion Regulation Questionnaire (10 items) that assess emotion regulatory process using reappraisal, suppression and regulating negative emotion. The questionnaire has 2 subscales: reappraisal (6 items, items 1-6) and suppression (4 items, items 7-10, 4 )
Values are: 1 - Strongly Disagree, 2 - Mostly Disagree, 3 - Somewhat Disagree, 4 - Neither Agree or Disagree, 5 - Somewhat Agree, 6 - Mostly Agree, 7 - Strongly Agree The investigators will sum 6 items to create a composite score for reappraisal, ranging from 6 to 42. The higher score, the higher appraisal. The investigators will sum 4 items to create a composite score for suppression, ranging from 4 to 28. The higher score, the higher suppression. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Emotion Regulation | Will be measured using the Emotion Regulation Questionnaire (10 items) that assess emotion regulatory process using reappraisal, suppression and regulating negative emotion. The questionnaire has 2 subscales: reappraisal (6 items, items 1-6) and suppression (4 items, items 7-10, 4 )
Values are: 1 - Strongly Disagree, 2 - Mostly Disagree, 3 - Somewhat Disagree, 4 - Neither Agree or Disagree, 5 - Somewhat Agree, 6 - Mostly Agree, 7 - Strongly Agree The investigators will sum 6 items to create a composite score for reappraisal, ranging from 6 to 42. The higher score, the higher appraisal. The investigators will sum 4 items to create a composite score for suppression, ranging from 4 to 28. The higher score, the higher suppression. |
24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Emotion Regulation | Will be measured using the Emotion Regulation Questionnaire (10 items) that assess emotion regulatory process using reappraisal, suppression and regulating negative emotion. The questionnaire has 2 subscales: reappraisal (6 items, items 1-6) and suppression (4 items, items 7-10, 4 )
Values are: 1 - Strongly Disagree, 2 - Mostly Disagree, 3 - Somewhat Disagree, 4 - Neither Agree or Disagree, 5 - Somewhat Agree, 6 - Mostly Agree, 7 - Strongly Agree The investigators will sum 6 items to create a composite score for reappraisal, ranging from 6 to 42. The higher score, the higher appraisal. The investigators will sum 4 items to create a composite score for suppression, ranging from 4 to 28. The higher score, the higher suppression. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Perceived Stress | Will be measured using The Perceived Stress Scale (10 items) that measures the degree to which situations in one's life are appraised as stressful.
Values are: 0 - Never, 1 - Almost Never, 2 - Sometimes, 3 - Fairly Often, 4 - Very Often The investigators will sum 10 items to create a composite score, ranging from 0 to 40. The higher score, the higher levels of perceived stress. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Perceived Stress | Will be measured using The Perceived Stress Scale (10 items) that measures the degree to which situations in one's life are appraised as stressful.
Values are: 0 - Never, 1 - Almost Never, 2 - Sometimes, 3 - Fairly Often, 4 - Very Often The investigators will sum 10 items to create a composite score, ranging from 0 to 40. The higher score, the higher levels of perceived stress. |
24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Perceived Stress | Will be measured using The Perceived Stress Scale (10 items) that measures the degree to which situations in one's life are appraised as stressful.
Values are: 0 - Never, 1 - Almost Never, 2 - Sometimes, 3 - Fairly Often, 4 - Very Often The investigators will sum 10 items to create a composite score, ranging from 0 to 40. The higher score, the higher levels of perceived stress. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Change in Executive Function | Will be measured using The Behavior Rating Inventory of Executive Function-Adults (BRIEF-A, 75 items). This survey measures an adult's executive function in her everyday environment: for example, inhibitory control, self-monitoring, plan/organization, and organization of materials.
Values are: 0 - Never, 1 - Sometimes, 2 - Often The investigators will sum 75 items to create a composite score, ranging from 0 to 150. The higher score, the lower executive function. |
Baseline: less than or equal to 16 week-gestation (T1) to 24-27 week-gestation (T2) | |
Secondary | Change in Executive Function | Will be measured using The Behavior Rating Inventory of Executive Function-Adults (BRIEF-A, 75 items). This survey measures an adult's executive function in her everyday environment: for example, inhibitory control, self-monitoring, plan/organization, and organization of materials.
Values are: 0 - Never, 1 - Sometimes, 2 - Often The investigators will sum 75 items to create a composite score, ranging from 0 to 150. The higher score, the lower executive function. |
24-27 week-gestation (T2) to 35-37 week-gestation (T3) | |
Secondary | Change in Executive Function | Will be measured using The Behavior Rating Inventory of Executive Function-Adults (BRIEF-A, 75 items). This survey measures an adult's executive function in her everyday environment: for example, inhibitory control, self-monitoring, plan/organization, and organization of materials.
Values are: 0 - Never, 1 - Sometimes, 2 - Often The investigators will sum 75 items to create a composite score, ranging from 0 to 150. The higher score, the lower executive function. |
Baseline: less than or equal to 16 week-gestation (T1) to 35-37 week-gestation (T3) | |
Secondary | Acceptability | Investigators will ask participants to evaluate the following: the usefulness (12 items) and satisfaction (12 items) of each intervention component.
Values are: 1 - not useful at all/not satisfy at all, 2, 3, 4 - very useful/very satisfy. The investigators will sum the 12 items to create a composite score, ranging from 12 to 48. The higher the score, the higher acceptability. |
35-37 week-gestation (T3) | |
Secondary | Process evaluation | Investigators will use 8 items to conduct process evaluation. Investigators will ask all study participants' receipt of stress or emotion management, healthy eating, and physical activity counseling from their clinicians, midwifes and dietitians (Yes = 1/No =0). If yes, they will be asked about the frequency and length. Participants will also be asked if they have joined/received other programs to manage stress better, eat healthier, and be more physically active.
The investigators will sum 8 items to create a composite score, ranging from 0 to 8). The higher score, the more consultation received from clinicians, midwifes and dietitians. |
35-37 week-gestation (T3) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |